Navigation Links
Pandemic in Medical Technology

NOVAVAX Achieves Pandemic H1N1 Influenza Production Milestone

... particle (VLP) vaccine candidate against the H1N1 pandemic influenza virus under current good-manufacturing ... has plans to produce additional batches of the pandemic H1N1 VLP vaccine to support human clinical ... influenza vaccine within 12 weeks under real pandemic conditions is an important and successful test of ...

Intercell AG Announces First Subject Enrolled in a Phase II Trial for the Further Development of Its Investigational Vaccine Enhancement Patch to Improve Pandemic Influenza Prevention in Collaboration With U.S. Department of Health and Human Services (HHS

... (VE) Patch in combination with an injectable H5N1 pandemic influenza vaccine started today in the U.S. ... the dosage and improve protection against an H5N1 pandemic influenza outbreak with only a single dose ... its VE Patch to improve prevention of H5N1 pandemic influenza with the start of a Phase II clinical ...

EPSScentral Responds to Pandemic Alert

... the WHO, phase 5 ... is a strong signal that a pandemic is imminent and that the time to ... ... and performance, EPSScentral, together with pandemic content experts and technology partners, developed a package to address pandemic planning needs. Commencing with the SARS and ...

USAID Cooperates in Pandemic Preparedness Initiative

... off the implementation stage of its Humanitarian pandemic Preparedness initiative. The three-day exercise ... emerging infectious disease will spark a global pandemic remains a significant threat. In a pandemic, ... need access to food, water, and care for both pandemic and non-pandemic illnesses. Through the ...

USAID Provides $5M in Emergency Support as Swine Flu Spreads

... 2005, USAID has committed $543 million to support pandemic prevention and preparedness across the globe," ... On April 27, WHO raised the level of influenza pandemic alert to Phase 4, indicating an increased ... alert level does not necessarily mean that a pandemic is inevitable. WHO sent a team of responders, ...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

... doses to, perhaps, several billion doses in a pandemic situation, company officials said. ... may provide some protection even against a pandemic caused by a different strain of H5N1. She also ... it may make sense to vaccinate people prior to a pandemic with the licensed vaccine and then, if ...

Novavax Presents Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program at World Health Organization Conference

... - Has Potential to Address Gaps in Global pandemic Preparedness ROCKVILLE, Md., Feb. 17 ... Health Organization Meeting on Evaluation of pandemic Influenza Prototype Vaccines in Clinical Trials, ... of the Phase I/IIa human clinical trial of its pandemic influenza virus-like particle (VLP) vaccine ...

USD 12.5 m Funding for the Development of Intercell's Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)

... additional funding of USD 12.5 m for Intercell's pandemic Influenza program. Intercell is developing a pandemic Influenza Vaccine Patch System that includes an ... immune response and enable dose sparing of the pandemic Influenza vaccine. The actual funding ...

Novavax Announces Top Line Results of Phase IIa Clinical Trial for Its Seasonal Influenza VLP (Trivalent) Vaccine Candidate

... vaccine program follows positive results from its pandemic influenza vaccine Phase IIa trial in July 2008; ... influenza results in combination with the pandemic influenza results released in August of this ... current results may not be predictive of future pandemic results, results of our seasonal influenza ...

Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans

... the company's Vaxfectin (R)-formulated H5N1 pandemic influenza DNA vaccines induced T-cell responses ... (Las Vegas - December 9-11). H5N1 pandemic Influenza Vaccine Phase 1 Trial Update New ... company's monovalent Vaxfectin(R)-formulated H5N1 pandemic influenza DNA vaccine induced T-cell responses ...

Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months

... influenza vaccine and with protein-based H5N1 pandemic influenza vaccine currently stockpiled by the ... the greatest number of people in the event of a pandemic influenza outbreak. Data from additional ... for specific applications. H5N1 pandemic Influenza Vaccine Phase 1 Trial Update Vical ...

ImmunoVaccine Technologies' DepoVax(TM) Shows Positive Results for Cancer and Infectious Diseases

... to be effective, which is not an option in a pandemic situation," said Mansour. "Our depot vaccine formulation makes a single-dose pandemic flu vaccine a strong possibility." IVT's strategy is multi-targeted; the company is exploring pandemic and seasonal influenza, as well as Hepatitis B. ...

Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program

... Potential to Address Gaps in Global pandemic Preparedness ROCKVILLE, Md., Aug. 26 ... of the Phase I/IIa human clinical trial of its pandemic influenza virus-like particle (VLP) vaccine ... has the potential to address an unmet need in pandemic influenza preparedness efforts being planned by ...

Vical Announces Breakthrough for Pandemic Influenza DNA Vaccines With Preliminary Human Data

... achieve significant immune responses against H5N1 pandemic influenza in humans. DNA vaccines are ... may offer compelling advantages in response to a pandemic outbreak because of significantly ... of the company's Vaxfectin(R)-formulated H5N1 pandemic influenza DNA vaccines demonstrated for the first ...

Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU

... with its intranasal vaccine deltaFLU against pandemic influenza. This novel generation of a ... The randomized, double-blind phase I study of the pandemic vaccine deltaFLU will be run at the Department of ... in healthy volunteers. Preclinical Data, pandemic Vaccine "Our vaccine lacks the pathogenicity ...

Sinovac Initiates Phase II Volunteer Enrollment for Split Viron Pandemic Influenza (H5N1) Vaccine

... in its Phase II clinical trial for its split pandemic influenza vaccine. The preliminary results from ... Phase II clinical trial of Panflu(TM), its pandemic influenza (H5N1) whole viron inactivated vaccine. ... (H5N1). Sinovac is currently developing Universal pandemic Influenza vaccine and Japanese encephalitis ...

Sanofi Pasteur to Donate 60 Million Doses of H5N1 Vaccine to WHO Over 3 Years for its Influenza Vaccine Global Stockpile

... poorest regions of the world and an outbreak of pandemic influenza would most likely hit populations ... the forefront of readiness against the threat of pandemic influenza. The company is committed to ... program and in an ambitious seasonal and pandemic influenza vaccine production plan. Each year ...

The New England Journal of Medicine Publishes Study Investigating the Safety and Efficacy of Baxter's Cell-Based Pandemic, Avian Flu Vaccine

... with the aim of protecting people against an H5N1 pandemic flu infection," said Hartmut J. Ehrlich, MD. ... Agency, making it the first cell culture-based pandemic influenza vaccine to be reviewed by the ... Ministry of Health to supply 16 million doses of pandemic influenza vaccine in the event a pandemic is ...

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation

... including a vaccine patch for pandemic influenza in Phase II. - Intercell will ... an immunostimulant vaccine patch in Phase II for pandemic influenza. This patch is designed to enhance the ... diarrhea available in the United States. About pandemic Influenza: Three influenza pandemics have ...

Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch

... vaccine. As the majority of current approaches to pandemic influenza vaccines require two doses, given 3 or ... in development: three targeting influenza and pandemic flu and one to prevent travelers' diarrhea. For ... health officials in addressing an outbreak of pandemic influenza; that the clinical trial data from the ...

Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch

... in combination with an injected vaccine for pandemic influenza, and data from a prior European trial ... of a dose-sparing patch for use with a pandemic influenza vaccine, and that contract is currently funding the Phase 1/2 pandemic influenza trial. The patch being used in that ...

Novavax Reports Fourth Quarter and 2007 Year-End Financial Results

... 1, 2007, Novavax has: -- Advanced its H5N1 pandemic influenza vaccine to Phase I/IIa clinical ... of 2008. The initial results from our pandemic influenza study bode well for our seasonal ... 2007 with GE Healthcare to co-market a pandemic influenza vaccine solution to select ...

Novavax Announces Favorable Interim Results from Human Clinical Trial for Its Pandemic Influenza Vaccine Program

... I/IIa human clinical trial of its non-adjuvanted pandemic influenza virus-like particle (VLP) vaccine ... and support further development of our pandemic influenza vaccine through regulatory licensure. ... the vaccine as part of our contribution to pandemic flu preparedness planning. Novavax has the ...

GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution

... a vaccine facility could allow manufacturing of pandemic flu vaccine to commence within 12 weeks of the ... a collaboration agreement to develop and market a pandemic influenza vaccine manufacturing solution for ... global avian flu pandemic: the global demand for pandemic influenza vaccine has been reported as possibly ...

U.S. Department of Health and Human Services Completes Funding of 2006 Contract Award to CSC's DVC and Baxter

... patients in a Phase 1 clinical trial for a pandemic influenza clade 2 strain vaccine candidate in ... conducted in the U.S. "The progress made on the pandemic and seasonal influenza programs in such a short ... to those using the vaccines and for government pandemic planning." About Baxter Baxter International ...

Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials

... an update on the clinical trials for its pandemic influenza vaccines. Sinovac received approval in ... vaccine and Phase I and II trials of its pandemic influenza (H5N1) split vaccine. In the pandemic influenza whole viron vaccine Phase II trial, a ...

Novavax Reports Third Quarter 2007 Financial Results and Progress with Vaccine Development Programs

... particle ("VLP")-based vaccine candidates against pandemic and seasonal influenza. "Financial results for ... the Phase I/IIa clinical trial of our novel pandemic vaccine from which scheduled top line results ... -- Scheduled results from our Phase I/IIa H5N1 pandemic flu vaccine trial. Third Quarter Financial ...

Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region

... The exercise uses a hypothetical but realistic pandemic flu outbreak in Greater Washington as the ... has been paid in recent years to preventing a pandemic flu outbreak, and we're encouraged by that," said ... set of events starting with the discovery of a pandemic flu outbreak in South America. As the exercise ...

Vical Demonstrates Dose-sparing of Protein-based H5N1 Influenza Vaccine With Vaxfectin(TM) Adjuvant

... as a dose-sparing agent with a protein-based H5N1 pandemic influenza vaccine currently stockpiled by the ... the greatest number of people in the event of a pandemic influenza outbreak. Alain Rolland, Pharm.D., ... influenza vaccines against seasonal or pandemic influenza strains; whether Vical or others will ...

Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine

... If successful, Iomai's approach may expand the pandemic influenza vaccine supply in the event of an ... to solve the pressing problem of inadequate pandemic vaccine stocks, and we believe the results of ... placebo injection or one of three dosages of pandemic influenza vaccine. Patients will receive a ...

Vical Begins Phase 1 Trial of DNA Vaccine Against H5N1 Pandemic Influenza

... clinical sites. "We have designed a promising pandemic influenza vaccine and demonstrated its ... begun testing in humans. The currently stockpiled pandemic influenza vaccines primarily generate antibody ... influenza vaccine in animals. pandemic Influenza Vaccine Background ...

GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.

... effectively respond to the global threat of a flu pandemic and we are pleased to be working with the US ... to U.S. production of 150 million doses of pandemic vaccine within six months of a pandemic onset. ... and manufacture cell-culture based seasonal and pandemic influenza vaccines. These cell culture vaccine ...

Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs

... of 2007, including acceleration of the company's pandemic influenza vaccine program, the company is ... and investments of $82 million at June 30, 2007. pandemic Influenza IND Allowed -- Vical has received ... of the company's Vaxfectin(TM)-formulated pandemic influenza DNA vaccine, and now expects to ...

Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health

... a pandemic. Baxter will manufacture its pandemic vaccine in a serum-free, vero cell-based system, ... to quickly respond to emerging variant pandemic virus strains. "We are proud to provide the ... further develop vero cell culture-based candidate pandemic and seasonal influenza vaccines in the United ...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

... strain change, which is expected to expedite the licensure process for the pandemic vaccine. "Filing this application is consistent with our ... evaluate the safety and potential benefits of adding an adjuvant to the pandemic vaccine. More information on the influenza A(H1N1) 2009 vaccine clinical ...

AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine

... responses, both of which could be important in the face of a developing pandemic where there are several variant virus forms circulating," said Jonathan ... to manufacture VRP vaccines and anticipate yields up to 1 million doses of pandemic influenza vaccine per lot at the 1,000 L bioreactor scale. Since the ...

Aethlon Medical to Present at the 2009 RedChip Small-Cap Investor Conference on June 16, 2009

... a broad-spectrum treatment countermeasure against bioterror and emerging pandemic threats. The Hemopurifier(R) also holds promise in cancer care, as ... with drug therapy, including several of world's deadliest bioterror and pandemic threats. These include: Dengue hemorrhagic fever (DHF), Ebola hemorrhagic ...

Insurance Industry Teleconference on Swine Flu Pandemic Set for May 13

... after the World Health Organization warned that a Swine Flu or A/H1N1 pandemic is imminent, a prominent insurance law firm announced it will host a ... for the industry to do at this point is to learn as much as it can about pandemic issues and responses to them by economies and by governments because the ...

Novavax Reports Positive Preclinical Results for a Novel, Broadly Cross-Protective H5N1 Pandemic Influenza Virus-like Particle (VLP) Vaccine Candidate

... today favorable preclinical results for a new broadly immunogenic pandemic influenza virus-like particle (VLP) vaccine candidate that provided ... of inducing broad cross protection against a variety of strains with pandemic potential without the use of an adjuvant. "It is extremely important to ...

NOVAVAX Featured at Clinton Global Initiative 2008 Annual Meeting

... and can be produced rapidly to supply vaccine against an emerging pandemic strain. The company has also commenced a Phase II trial in healthy adults ... under development; current results may not be predictive of future pandemic results, results of our seasonal influenza vaccine or any other vaccine ...
Other Contents
(Date:10/16/2014)... Institute of Marine Science have received a 3-year, ... identify the streams and wetlands most vulnerable to ... local governments and citizens conserve these important ecosystems. ... of tidal-marsh observations first gathered by VIMS scientists ... can today,s researchers accurately map the slow but ...
(Date:10/16/2014)... Calif. (October 16, 2014) – Post-menopausal women experienced ... on hormone levels or genital bleeding, after 12 ... an investigational fermented soy germ-based nutritional supplement previously ... to a new peer-reviewed pilot study reported in ... (NAMS) annual scientific meeting. , "These data ...
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
Breaking Biology News(10 mins):EPA grant will help localities conserve headwater wetlands 2EPA grant will help localities conserve headwater wetlands 3S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 ... non-profit organization that helps New Yorkers living with ... changes toward health, housing, recovery and self-sufficiency. Each ... transformed the local community through their tireless efforts. ... Marc Shapses , has been selected as ...
(Date:10/20/2014)... 2014 JZ Fitness, an independently operated ... wellness programming, authorship, international lecturing and community wellness, created ... the release of the JZ Fitness nutrition app, available ... coaching thousands of individuals on nutrition, Jenn Zerling (“JZ”) ... not require calorie counting or cumbersome food logging. ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Rockynol ... Living Center on Oct. 14. The $11 million project ... services, and a cooked-to-order kitchen with full-service restaurant style ... premier choice for first class Assisted Living apartments,” said ... residents deserve the highest quality of care and this ...
(Date:10/20/2014)... October 20, 2014 Unveiled at the Sept. ... Direction Scorecard conservatively estimates member hospital ROI on membership dues ... dues, The Center provides $12.50 in value to member hospitals. ... Value – Member Dues)/Member Dues. , “This is the ... number and we think the methodology is really sound,” said ...
(Date:10/19/2014)... Hastings and Hastings, a Phoenix personal ... throughout the greater Phoenix area and across Arizona reports ... to catastrophic automobile accidents. Statistics have indicated a steady ... Arizona. As such, Hastings and Hastings has seen a ... those who have been injured through no fault of ...
Breaking Medicine News(10 mins):Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:JZ Fitness Nutrition App Launches on iTunes 2Health News:JZ Fitness Nutrition App Launches on iTunes 3Health News:Rockynol Retirement Community Expands Assisted Living Center 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 2Health News:Hastings And Hastings Reports Record Demand In 2014 For Legal Representation With Regard To Catastrophic Automobile Accidents 3
Other TagsOther Tags